Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
NSRX

Nasus Pharma (NSRX) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $3.51 -3.3% on the day -54.7% over 12 months 52-week range $2.01 – $9.15

Share price and insider trades

NSRX closeInsider buyInsider sale
025810NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $10,904 on 2026-04-22 · Dan Benjamin TelemanBought $20,305 on 2026-06-17 · Dan Benjamin TelemanBought $30,600 on 2026-03-31 · Dan Benjamin Teleman
Bought, 12 months$62K
Sold, 12 months$0
Insiders buying1
Insiders selling0

Nasus Pharma insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $62K and 0 sold $0 of NSRX stock on the open market.

NSRX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $31K bought (1 trades)$31KQ1 2026Q2 2026: $31K bought (2 trades)$31KQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$31K2—0
Q1 2026$31K1—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit+$24KOn all tracked purchases +38.8%

Summary

Over the past 12 months, 1 Nasus Pharma Ltd insider reported open-market purchases totaling $62K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Dan Benjamin Teleman (CEO) has the highest Insider Score at 51.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jun 22SEC Dan Benjamin TelemanCEO Buy 6,550163,541 held (+4%) $3.10 $20K +13.2% 51
Apr 22SEC Dan Benjamin TelemanCEO Buy 2,900156,991 held (+2%) $3.76 $11K -6.6% 51
Apr 1SEC Dan Benjamin TelemanCEO Buy 15,00021,246 held (+240%) $2.04 $31K +72.1% 51

Insiders at Nasus Pharma Ltd

InsiderBoughtSoldLast filingScore
Dan Benjamin TelemanCEO $62K — Jun 22, 2026 51

NSRX stock: common questions

Are Nasus Pharma Ltd insiders buying NSRX stock?

In the past 12 months, 1 insiders reported open-market purchases of NSRX worth $62K. The latest was CEO Dan Benjamin Teleman bought $20K of NSRX at $3.10.

Are Nasus Pharma Ltd insiders selling NSRX stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is NSRX's 52-week range?

Over the past year NSRX has traded between $2.01 and $9.15. It last closed at $3.51 on Oct 9, 2026.